Oragenics Inc.

AMEX: OGEN · Real-Time Price · USD
1.14
-0.05 (-4.20%)
At close: Aug 15, 2025, 3:59 PM
1.15
0.88%
After-hours: Aug 15, 2025, 05:42 PM EDT

Oragenics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 37.65K 131.52K 86.99K
Cost of Revenue
4.11M 15.49M 44.67K 41.24K
Gross Profit
-4.11M -27.39K 86.85K 45.75K
Operating Income
-10.56M -10.67M -14.42M -15.77M
Interest Income
45.9K 179.8K 135.9K 75.85K
Pretax Income
-10.57M -20.66M -14.29M -15.71M
Net Income
-10.57M -20.66M -14.29M -15.71M
Selling & General & Admin
6.44M 5.45M 4.47M 5.27M
Research & Development
4.11M 15.49M 10.07M 10.59M
Other Expenses
-4.11M -10.3M 5K -85.63K
Operating Expenses
6.44M 10.64M 14.55M 15.77M
Interest Expense
29.83K 30.59K 15.1K 15.76K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
10.56M 20.94M 14.55M 15.86M
Income Tax Expense
n/a n/a -127K 16.43K
Shares Outstanding (Basic)
6.62M 2.25M 2.01M 1.88M
Shares Outstanding (Diluted)
6.62M 2.25M 2.01M 1.88M
EPS (Basic)
-1.6 -9.18 -7.11 -8.09
EPS (Diluted)
-1.6 -9.18 -7.11 -8.09
EBITDA
-10.56M -20.88M -14.23M -15.65M
EBIT
-10.6M -20.91M -14.27M -15.7M
Depreciation & Amortization
38.93K 27.39K 44.67K 41.24K